Sanil Bhatia

1.3k total citations
40 papers, 534 citations indexed

About

Sanil Bhatia is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Sanil Bhatia has authored 40 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Hematology. Recurrent topics in Sanil Bhatia's work include Histone Deacetylase Inhibitors Research (13 papers), Acute Lymphoblastic Leukemia research (9 papers) and Protein Degradation and Inhibitors (8 papers). Sanil Bhatia is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Acute Lymphoblastic Leukemia research (9 papers) and Protein Degradation and Inhibitors (8 papers). Sanil Bhatia collaborates with scholars based in Germany, United States and China. Sanil Bhatia's co-authors include Arndt Borkhardt, Finn K. Hansen, Andrea Schöler, Julia Hauer, Frank Bauer, Nina Reßing, David W. Christianson, Matthias U. Kassack, J.D. Osko and Thomas Kurz and has published in prestigious journals such as Angewandte Chemie International Edition, Blood and Clinical Infectious Diseases.

In The Last Decade

Sanil Bhatia

36 papers receiving 532 citations

Peers

Countries citing papers authored by Sanil Bhatia

Since Specialization

Citations

This map shows the geographic impact of Sanil Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanil Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanil Bhatia more than expected).

Fields of papers citing papers by Sanil Bhatia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanil Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanil Bhatia. The network helps show where Sanil Bhatia may publish in the future.

Co-authorship network of co-authors of Sanil Bhatia

This figure shows the co-authorship network connecting the top 25 collaborators of Sanil Bhatia. A scholar is included among the top collaborators of Sanil Bhatia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanil Bhatia. Sanil Bhatia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies 2026 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Gütschow, Radosław P. Nowak, Christian Steinebach, Sanil Bhatia, Finn K. Hansen	0
2	Deep transfer learning approach for automated cell death classification reveals novel ferroptosis-inducing agents in subsets of B-ALL 2025 ·Cell Death and Disease ·(unknown), Zhe Lü, (unknown), Haifeng C. Xu, (unknown), (unknown), K. P. Schaal, (unknown), Daniel Picard, Silvia von Karstedt, Ute Fischer, Sanil Bhatia, Philipp A. Lang, Arndt Borkhardt, Aleksandra A. Pandyra	0
3	Pharmacological Inhibition of MDM2 Induces Apoptosis in p53-Mutated Triple-Negative Breast Cancer 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sanil Bhatia, (unknown), Dieter Niederacher, Hans Neubauer, Thomas Kurz, Tanja Fehm, Knud Esser	3
4	Novel meriolin derivatives activate the mitochondrial apoptosis pathway in the presence of antiapoptotic Bcl-2 2024 ·Cell Death Discovery ·(unknown), (unknown), (unknown), Hector Flores‐Romero, Margaretha A. Skowron, (unknown), (unknown), (unknown), (unknown), Christoph Peter, Björn Stork, Nan Qin, Sanil Bhatia, Daniel Nettersheim, Gerhard Fritz, Ana J. García‐Sáez, Thomas J. J. Müller, Sebastian Wesselborg	5
5	Novel meriolin derivatives potently inhibit cell cycle progression and transcription in leukemia and lymphoma cells via inhibition of cyclin-dependent kinases (CDKs) 2024 ·Cell Death Discovery ·(unknown), (unknown), (unknown), Peter‐Martin Bruch, (unknown), (unknown), (unknown), Christoph Peter, Sanil Bhatia, Sascha Dietrich, Björn Stork, Gerhard Fritz, Holger Gohlke, Thomas J. J. Müller, Sebastian Wesselborg	7
6	Hyperdiploid acute lymphoblastic leukemia in children with LZTR1 germline variants 2024 ·HemaSphere ·(unknown), Rabea Wagener, Ute Fischer, Anna Hoffmann, (unknown), (unknown), (unknown), (unknown), Carolin Walter, Julian Varghese, Julia Hauer, Franziska Auer, Sanil Bhatia, Martin Dugas, Stefanie V. Junk, Martin Stanulla, Oskar A. Haas, Arndt Borkhardt, Tobias Reiff, Triantafyllia Brozou	2
7	Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 2024 ·Heliyon ·(unknown), (unknown), (unknown), (unknown), Angela Maria Savino, (unknown), Michela Bardini, Grazia Fazio, Silvia Bresolin, Andrea Biondi, Arndt Borkhardt, Sanil Bhatia, Giovanni Cazzaniga, Chiara Palmi	3
8	High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 2023 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Angela Maria Savino, Daniela Silvestri, Maria Grazia Valsecchi, Andrea Biondi, Arndt Borkhardt, Sanil Bhatia, Giovanni Cazzaniga, Grazia Fazio, Michela Bardini, Chiara Palmi	11
9	The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism 2022 ·Cell Death and Disease ·Fabian Stuhldreier, (unknown), Thomas Lenz, (unknown), Marcel Zimmermann, (unknown), (unknown), Yang Liu, Paul F. Jäger, Stefanie Geyh, Nicole Teusch, Christoph Peter, Sanil Bhatia, Rainer Haas, Bodo Levkau, Andreas S. Reichert, Kai Stühler, Peter Proksch, Björn Stork, Sebastian Wesselborg	7
10	Prenylated cyclohexene-type meroterpenoids and sulfur-containing xanthones produced by Pseudopestalotiopsis theae 2022 ·Phytochemistry ·Sergi Hervé Akoné, Hao Wang, (unknown), Attila Mándi, Tibor Kurtán, (unknown), Rudolf Hartmann, Sanil Bhatia, Jing Yang, Wernér E.G. Müller, Daowan Lai, Zhen Liu, Rainer Kalscheuer, Peter Proksch	8
11	4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads 2021 ·Journal of Medicinal Chemistry ·Linda Schäker‐Hübner, (unknown), (unknown), Pankaj Mishra, (unknown), (unknown), Andrea Schöler, Arndt Borkhardt, Bernhard Breit, Sanil Bhatia, (unknown), Stefan Günther, Finn K. Hansen	31
12	CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL 2021 ·Cancer Immunology Immunotherapy ·(unknown), D. A. Vallera, Angela R. Manser, (unknown), Sanil Bhatia, Martin Felices, Jeffrey S. Miller, Markus Uhrberg, Florian Babor	31
13	Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors 2020 ·European Journal of Medicinal Chemistry ·Leandro A. Alves Avelar, (unknown), (unknown), Alexandra Hamacher, Finn K. Hansen, (unknown), Arndt Borkhardt, Sanil Bhatia, Matthias U. Kassack, Thomas Kurz	16
14	JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility 2019 ·Leukemia ·(unknown), Karin Nebral, Christoph G. W. Gertzen, Ithamar Ganmore, Oskar A. Haas, Sanil Bhatia, Ute Fischer, Michaela Kuhlen, Holger Gohlke, Shai Izraeli, Jan Trka, Jianda Hu, Arndt Borkhardt, Julia Hauer, Franziska Auer	11
15	Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor 2018 ·Journal of Medicinal Chemistry ·Sanil Bhatia, (unknown), M. Groll, J.D. Osko, Nina Reßing, (unknown), Arndt Borkhardt, Thomas Kurz, David W. Christianson, Julia Hauer, Finn K. Hansen	62
16	Nucleolin promotes execution of the hematopoietic stem cell gene expression program 2018 ·Leukemia ·Csaba Mahotka, Sanil Bhatia, Jutta Kollet, Edgar Grinstein	11
17	The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells 2018 ·Haematologica ·(unknown), (unknown), Franziska Auer, Sanil Bhatia, (unknown), Daniel Picard, Marc Remke, Jessica I. Hoell, Andreas Kloetgen, Dennis Sohn, Reiner U. Jänicke, Gesine Koegler, Arndt Borkhardt, Julia Hauer	13
18	Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight? 2018 ·Frontiers in Immunology ·Sujal Ghosh, Ingo Drexler, Sanil Bhatia, Heiko Adler, Andrew R. Gennery, Arndt Borkhardt	27
19	Mouse models for pre-clinical drug testing in leukemia 2016 ·Expert Opinion on Drug Discovery ·Sanil Bhatia, Svenja Daschkey, Franziska Lang, Arndt Borkhardt, Julia Hauer	4
20	GEMMs addressing Pax5 loss-of-function in childhood pB-ALL 2015 ·European Journal of Medical Genetics ·Franziska Auer, (unknown), Sanil Bhatia, Jürgen Enczmann, César Cobaleda, Isidro Sánchez‐García, Arndt Borkhardt, Julia Hauer	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact